276 related articles for article (PubMed ID: 37099180)
1. [Eosinophilia: hypereosinophilic syndrome vs. eosinophilic granulomatosis with polyangiitis].
Holle JU; Moosig F
Z Rheumatol; 2023 May; 82(4):307-320. PubMed ID: 37099180
[TBL] [Abstract][Full Text] [Related]
2. A new index for distinguishing hypereosinophilic syndrome and antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis.
Ahn SS; Yoo J; Park YB; Park JW; Lee JH; Lee SW
Asian Pac J Allergy Immunol; 2023 Sep; 41(3):244-252. PubMed ID: 33068368
[TBL] [Abstract][Full Text] [Related]
3. Unmet needs and evidence gaps in hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis.
Wechsler ME; Hellmich B; Cid MC; Jayne D; Tian X; Baylis L; Roufosse F
J Allergy Clin Immunol; 2023 Jun; 151(6):1415-1428. PubMed ID: 37086239
[TBL] [Abstract][Full Text] [Related]
4. "Idiopathic Eosinophilic Vasculitis": Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free Patients.
Lefèvre G; Leurs A; Gibier JB; Copin MC; Staumont-Sallé D; Dezoteux F; Chenivesse C; Lopez B; Terriou L; Hachulla E; Launay D; Etienne N; Labalette M; DeGroote P; Pontana F; Quemeneur T; Hatron PY; Schleinitz N; Viallard JF; Hamidou M; Martin T; Morati-Hafsaoui C; Groh M; Lambert M; Kahn JE;
J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1329-1340.e3. PubMed ID: 31863912
[TBL] [Abstract][Full Text] [Related]
5. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
[TBL] [Abstract][Full Text] [Related]
6. Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.
Frątczak A; Polak K; Miziołek B; Bergler-Czop B
Acta Dermatovenerol Croat; 2022 Sep; 30(2):116-118. PubMed ID: 36254546
[TBL] [Abstract][Full Text] [Related]
7. Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis.
Bouiller K; Samson M; Eicher JC; Audia S; Berthier S; Leguy V; Humbert O; Martin L; Lorgis L; Cottin Y; Bonnotte B; Lorcerie B
Intern Med J; 2014 Sep; 44(9):928-31. PubMed ID: 25201426
[TBL] [Abstract][Full Text] [Related]
8. Churg-Strauss syndrome.
Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M
Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434
[TBL] [Abstract][Full Text] [Related]
9. [Eosinophilic granulomatosis with polyangiitis : Update on classification and management].
Hellmich B; Holle J; Moosig F
Z Rheumatol; 2022 May; 81(4):286-299. PubMed ID: 35075511
[TBL] [Abstract][Full Text] [Related]
10. Justification of the Subcutaneous Mepolizumab Dose of 300 mg in Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome.
Pouliquen IJ; Austin D; Steinfeld J; Yancey SW
Clin Ther; 2021 Jul; 43(7):1278-1280. PubMed ID: 34187697
[No Abstract] [Full Text] [Related]
11. [Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].
Jerrentrup A; Müller T; Mariss J; Dylla S
Internist (Berl); 2018 May; 59(5):497-504. PubMed ID: 28983650
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management.
Trivioli G; Terrier B; Vaglio A
Rheumatology (Oxford); 2020 May; 59(Suppl 3):iii84-iii94. PubMed ID: 32348510
[TBL] [Abstract][Full Text] [Related]
13. [Current treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].
Moosig F; Holle J
Z Rheumatol; 2019 May; 78(4):333-338. PubMed ID: 30627842
[TBL] [Abstract][Full Text] [Related]
14. Renal Involvement as Rare Acute Tubulointerstitial Nephritis in a Patient with Eosinophilic Disorder Treated with Early Add-on Administration of Mepolizumab.
Hayama Y; Tomyo F; Ueno M; Asakawa S; Arai S; Yamazaki O; Tamura Y; Mochizuki M; Ohashi R; Shibata S; Fujigaki Y
Intern Med; 2021 Dec; 60(23):3759-3764. PubMed ID: 34092738
[TBL] [Abstract][Full Text] [Related]
15. Radiological and Clinical Features of Eosinophilic Granulomatosis with Polyangiitis.
Xu XL; Song W; Sui X; Song L; Du QN; Wang X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):617-620. PubMed ID: 27825424
[TBL] [Abstract][Full Text] [Related]
16. Eosinophilic granulomatosis with polyangiitis.
Romero Gómez C; Hernández Negrín H; Ayala Gutiérrez MDM
Med Clin (Barc); 2023 Apr; 160(7):310-317. PubMed ID: 36774291
[TBL] [Abstract][Full Text] [Related]
17. Severe eosinophilic granulomatosis with polyangiitis responding to a combination of rituximab and mepolizumab.
Tsioulos G; Kounatidis D; Vallianou NG; Koufopoulos N; Katsimbri P; Antoniadou A
Am J Med Sci; 2023 Jan; 365(1):93-98. PubMed ID: 35970248
[TBL] [Abstract][Full Text] [Related]
18. C-Reactive protein as a diagnostic tool in differential diagnosis of hypereosinophilic syndrome and antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis.
Leurs A; Chenivesse C; Lopez B; Gibier JB; Clément G; Groh M; Copin MC; Staumont-Sallé D; Mortuaire G; Balquet MH; Dezoteux F; Bautin N; Buchdahl AL; Le Gouellec N; Etienne N; Terriou L; Dubucquoi S; Labalette M; Morell-Dubois S; Maillard-Lefebvre H; Lambert M; Hachulla E; Launay D; Kahn JE; Hatron PY; Lefèvre G
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1347-1351.e3. PubMed ID: 30317003
[No Abstract] [Full Text] [Related]
19. Update on eosinophilic granulomatosis with polyangiitis.
Furuta S; Iwamoto T; Nakajima H
Allergol Int; 2019 Oct; 68(4):430-436. PubMed ID: 31266709
[TBL] [Abstract][Full Text] [Related]
20. Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
Pagnoux C; Groh M
Expert Rev Clin Immunol; 2016 Oct; 12(10):1059-67. PubMed ID: 27191665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
